Examining the Utility of In Vitro Bioactivity as a Conservative Point of Departure: A Case Study Katie Paul-Friedman Russell Thomas 10.23645/epacomptox.6879635.v1 https://epa.figshare.com/articles/presentation/Examining_the_Utility_of_In_Vitro_Bioactivity_as_a_Conservative_Point_of_Departure_A_Case_Study/6879635 Presentation at RIVM (Netherlands National Institute for Public Health and the Environment) visit to EPA April 2018 2018-07-30 19:42:49 bioactivity data high-throughput toxicokinetics ToxCast point of departure Toxicology